MedTrace Logo

Clinical and Radiological Outcomes of Medacta Shoulder System

NCT03547947 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a post-marketing surveillance on Medacta Shoulder System

Conditions

  • Primary Osteoarthritis
  • Secondary Osteoarthritis
  • Rotator Cuff Tear Arthropathy
  • Rheumatoid Arthritis Shoulder
  • Avascular Necrosis
  • Fracture
  • Revision of Shoulder Arthroplasty

Interventions

DEVICE

Medacta Shoulder System

Total Shoulder Arthroplasty

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Matthias Zumstein, Prof Dr. Med · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2031-04-30
Completion
2031-04-30

Countries

  • France
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547947 on ClinicalTrials.gov